Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonia Agustí

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
British Journal of Clinical Pharmacology|February 16, 2018
Non-commercial vs. commercial clinical trials: a retrospective study of the applications submitted to a research ethics committeeInmaculada Fuentes Camps, Alexis Rodríguez, Antonia Agustí
Cytotherapy|January 23, 2021
Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United StatesCarolina Iglesias-Lopez, Mercè Obach, Antonio Vallano, et al.
Molecular Therapy. Methods & Clinical Development|December 13, 2021
Current landscape of clinical development and approval of advanced therapiesCarolina Iglesias-Lopez, Antonia Agustí, Antoni Vallano, et al.
Frontiers in Pharmacology|September 24, 2019
Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United StatesCarolina Iglesias-López, Antonia Agustí, Mercè Obach, et al.
Frontiers in Pharmacology|June 12, 2020
Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United StatesCarolina Iglesias-Lopez, Antonia Agustí, Mercè Obach, et al.
Frontiers in Pharmacology|May 8, 2026
Opioid analgesic use during pregnancy: a drug utilization cohort study in CataloniaVeerle Driessen, Lina Camacho-Arteaga, Maria Giner-Soriano, et al.
Pharmacological Research|October 21, 2023
Clinical pharmacology facing the real-world setting: Pharmacovigilance, pharmacoepidemiology and the economic evaluation of drugsAntonia Agustí, Gloria Cereza, Francisco J de Abajo, et al.
Gaceta Sanitaria|December 14, 2011
[Systematic review of studies assessing the cost of adverse drug reactions]Antonio Vallano Ferraz, Antonia Agustí Escasany, Consuelo Pedrós Xolvi, et al.
BMC Research Notes|November 19, 2010
Educational sessions in pharmacovigilance: What do the doctors think?Antonio Vallano, Consuelo Pedrós, Antonia Agustí, et al.
European Journal of Clinical Pharmacology|June 17, 2010
Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospitalGloria Cereza, Antonia Agustí, Consuelo Pedrós, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|February 16, 2018
Non-commercial vs. commercial clinical trials: a retrospective study of the applications submitted to a research ethics committeeInmaculada Fuentes Camps, Alexis Rodríguez, Antonia Agustí
Cytotherapy|January 23, 2021
Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United StatesCarolina Iglesias-Lopez, Mercè Obach, Antonio Vallano, et al.
Molecular Therapy. Methods & Clinical Development|December 13, 2021
Current landscape of clinical development and approval of advanced therapiesCarolina Iglesias-Lopez, Antonia Agustí, Antoni Vallano, et al.
Frontiers in Pharmacology|September 24, 2019
Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United StatesCarolina Iglesias-López, Antonia Agustí, Mercè Obach, et al.
Frontiers in Pharmacology|June 12, 2020
Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United StatesCarolina Iglesias-Lopez, Antonia Agustí, Mercè Obach, et al.
Frontiers in Pharmacology|May 8, 2026
Opioid analgesic use during pregnancy: a drug utilization cohort study in CataloniaVeerle Driessen, Lina Camacho-Arteaga, Maria Giner-Soriano, et al.
Pharmacological Research|October 21, 2023
Clinical pharmacology facing the real-world setting: Pharmacovigilance, pharmacoepidemiology and the economic evaluation of drugsAntonia Agustí, Gloria Cereza, Francisco J de Abajo, et al.
Gaceta Sanitaria|December 14, 2011
[Systematic review of studies assessing the cost of adverse drug reactions]Antonio Vallano Ferraz, Antonia Agustí Escasany, Consuelo Pedrós Xolvi, et al.
BMC Research Notes|November 19, 2010
Educational sessions in pharmacovigilance: What do the doctors think?Antonio Vallano, Consuelo Pedrós, Antonia Agustí, et al.
European Journal of Clinical Pharmacology|June 17, 2010
Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospitalGloria Cereza, Antonia Agustí, Consuelo Pedrós, et al.
Pageof 3